[go: up one dir, main page]

BG103648A - Paroxetin-containing compositions - Google Patents

Paroxetin-containing compositions

Info

Publication number
BG103648A
BG103648A BG103648A BG10364899A BG103648A BG 103648 A BG103648 A BG 103648A BG 103648 A BG103648 A BG 103648A BG 10364899 A BG10364899 A BG 10364899A BG 103648 A BG103648 A BG 103648A
Authority
BG
Bulgaria
Prior art keywords
paroxetin
containing compositions
solutions
anhydrate
atomization
Prior art date
Application number
BG103648A
Other languages
Bulgarian (bg)
English (en)
Inventor
Victor JACEWICZ
Neal Ward
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700692.8A external-priority patent/GB9700692D0/en
Priority claimed from GBGB9714873.8A external-priority patent/GB9714873D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG103648A publication Critical patent/BG103648A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG103648A 1997-01-15 1999-08-10 Paroxetin-containing compositions BG103648A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9700692.8A GB9700692D0 (en) 1997-01-15 1997-01-15 Novel process and compound
GBGB9714873.8A GB9714873D0 (en) 1997-07-15 1997-07-15 Novel process and compound
PCT/GB1998/000081 WO1998031365A1 (en) 1997-01-15 1998-01-12 Paroxetine compositions

Publications (1)

Publication Number Publication Date
BG103648A true BG103648A (en) 2000-04-28

Family

ID=26310796

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103648A BG103648A (en) 1997-01-15 1999-08-10 Paroxetin-containing compositions

Country Status (21)

Country Link
US (1) US20010049442A1 (xx)
EP (1) EP0952831A1 (xx)
JP (1) JP2001508460A (xx)
KR (1) KR20000070151A (xx)
CN (1) CN1249686A (xx)
AP (1) AP9901604A0 (xx)
AU (1) AU730532B2 (xx)
BG (1) BG103648A (xx)
BR (1) BR9806754A (xx)
CA (1) CA2277480A1 (xx)
EA (1) EA002034B1 (xx)
HU (1) HUP0000960A3 (xx)
ID (1) ID23250A (xx)
IL (1) IL130856A (xx)
NO (1) NO993460L (xx)
NZ (1) NZ336587A (xx)
OA (1) OA11077A (xx)
PL (1) PL334568A1 (xx)
SK (1) SK95099A3 (xx)
TR (1) TR199901622T2 (xx)
WO (1) WO1998031365A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
TR200100444T2 (tr) * 1998-08-07 2001-07-23 Smithkline Beecham P.L.C. Paroksetin Hidroklorid'in bir kristalin olmayan anhidrat formunun hazırlanma yöntemi
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
CA2367402C (en) 1999-03-12 2010-11-23 Basf Aktiengesellschaft Stable pharmaceutical dosage form for paroxetine anhydrate
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
JP2003503493A (ja) 1999-07-01 2003-01-28 イタルファルマコ ソシエタ ペル アチオニ パロキセチンとシクロデキストリンまたはシクロデキストリン誘導体との錯体
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
WO2002017921A2 (en) * 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
ID23250A (id) 2000-03-30
PL334568A1 (en) 2000-03-13
BR9806754A (pt) 2000-03-14
CN1249686A (zh) 2000-04-05
IL130856A (en) 2001-09-13
WO1998031365A1 (en) 1998-07-23
NO993460D0 (no) 1999-07-14
SK95099A3 (en) 2000-01-18
TR199901622T2 (xx) 1999-09-21
NO993460L (no) 1999-09-14
AU5567398A (en) 1998-08-07
NZ336587A (en) 2001-01-26
CA2277480A1 (en) 1998-07-23
OA11077A (en) 2003-03-13
EP0952831A1 (en) 1999-11-03
AU730532B2 (en) 2001-03-08
EA002034B1 (ru) 2001-12-24
IL130856A0 (en) 2001-01-28
HUP0000960A3 (en) 2001-04-28
AP9901604A0 (en) 1999-09-30
KR20000070151A (ko) 2000-11-25
JP2001508460A (ja) 2001-06-26
HUP0000960A2 (hu) 2001-02-28
EA199900655A1 (ru) 2000-02-28
US20010049442A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
BG103648A (en) Paroxetin-containing compositions
IL132107A0 (en) Substituted phenyl derivatives their preparation and use
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
EP0992501A3 (en) Pyridonecarboxylic acid derivatives as antibacterial agents
TW334436B (en) Antiparasitic marcfortines and paraherquamides
CA2334730A1 (en) Novel cyclosporins
CA2414018A1 (en) 2-aminocarbonyl-9h-purine derivatives
AP2002002637A0 (en) Novel piperazine
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
BG103882A (en) Voriconazol-containing pharmaceutical compositions
WO2000039083A3 (en) Pyrazole compounds and uses thereof
BG103863A (en) Indazolamide compounds as serotoninergic forms
ATE214698T1 (de) Neue carbamazepin hapten analoge
CA2237189A1 (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
CA2383351A1 (en) Xanthine derivatives as selective antagonists of a2b adenosine receptors
MX9801967A (es) Tetrahidroquinolinas como antagonistas de los aminoacidos excitadores (nmda).
WO2002032901A3 (en) Bridged piperazine derivatives
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
TR199902019T2 (xx) �kame edilmi� tiazolidion' un haz�rlanmas� i�in proses.
CA2323047A1 (en) Prodrugs of benzofuranylmethyl carbamate nk, antagonists
GR3003738T3 (xx)
MX9500363A (es) Monohiddrato de (e)-2'-desoxi-2'- (fluorometilen) citidina.
CA2112061A1 (en) Alkyl substituted heterocyclic compounds
MX9603199A (es) Antagonistas de receptores a endotelina.